Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aarathi Cholkeri

Gynecology El Segundo, CA Medical Doctor

NPI 1205857281 CMS profile 54971

2151 E Grand Ave, El Segundo, CA 90245

Open in the dashboard

General payments

$127,853

202 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aarathi Cholkeri of El Segundo, CA is reported in the CMS Open Payments database as having received $127,853 across 202 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $56 1
2024 General $147 3
2023 General $270 3
2020 General $9,386 21
2019 General $117,995 174

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aarathi Cholkeri
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Aarathi Cholkeri were reported at $56. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Aarathi Cholkeri Gynecology median Middle half National median
2019 $117,995 $199 $66–$472 $163
2020 $9,386 $114 $42–$287 $114
2021 $0 $141 $42–$430 $132
2022 $0 $173 $52–$532 $149
2023 $270 $170 $57–$501 $160
2024 $147 $157 $50–$424 $164
2025 $56 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $81,386 109 payments
  2. Covidien LP $15,998 44 payments
  3. Daiichi Sankyo Inc. $10,620 15 payments
  4. American Regent $6,762 1 payment
  5. Boston Scientific Corporation $5,873 5 payments
  6. KARL STORZ Endoscopy-America $3,381 4 payments
  7. Caldera Medical, Inc $2,008 2 payments
  8. Olympus Corporation $485 1 payment
  9. Transenterix, Inc. $376 6 payments
  10. Bayer HealthCare Pharmaceuticals Inc. $350 1 payment
  11. Other $615 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $68,190 30 payments
  2. Consulting Fee $40,192 17 payments
  3. Travel and Lodging $13,340 43 payments
  4. Food and Beverage $6,113 111 payments
  5. Gift $18 1 payment
Products named General payments · program years 2019–2025
  1. Orilissa $72,053 94 payments
  2. INJECTAFER $17,382 16 payments
  3. TruClear $15,566 37 payments
  4. GENERAL UTERINE TISSUE REMOVAL $5,494 4 payments
  5. SCISSORS,HORIZ CUT,RIGHT,SNGL $3,000 1 payment
  6. Desara $2,008 2 payments
  7. Vertessa $1,563 1 payment
  8. GENERAL THERAPIES $378 1 payment
  9. Kyleena $350 1 payment
  10. Mirena $350 1 payment
  11. Other $2,176 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

202 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record